Swedish Multiple Sclerosis Blog

« Previous 12345 Next »
Viewing Page 1 of 28 | Showing Results 1 - 10 of 277

Anything worth doing is hard

May 16, 2016
by: Phil See
In October 2002, some colleagues and I, all musicians, had agreed to provide entertainment for a Halloween party at the organization where I worked. I was to play keyboards and sing. Two days prior to the event, I got up to get a glass of water and my right ear started ringing. I felt lightheaded and then I noticed my entire left side went a little numb. That day changed my life, but I took control.

A new look at MS and pregnancy

April 21, 2016

Doctors have known for years that most women with multiple sclerosis (MS) feel better and have fewer relapses when they are pregnant. Researchers have speculated that fluctuating hormones may be linked to this improvement in health. But studies on MS and hormones during pregnancy have had mixed results. I’ve changed my thinking on this and I’m embarking on new research that involves microchimerism.

Multiple Sclerosis patients by the numbers

April 11, 2016

How many people in the United States have multiple sclerosis? As it turns out, to answer this seemingly simple question is quite challenging.

Potential MS drug gets fast track designation

April 05, 2016

The Food and Drug Administration (FDA) has granted “fast track” designation for ibudilast, a medication that could help prevent damage to the brain in people with progressive multiple sclerosis.

Can you go back? Life before and after MS

March 30, 2016

MS changes lives. What does this change look like? Should we accept it?

MS Center’s new play-reading group – bring your inner ham

March 23, 2016

Have you ever wanted to act in a play? Are you a theater person who does not act anymore? Join the MS Center’s new Play Reading Group for a fun, light-hearted way to get into character. With the assistance of a dramaturgist at the National Multiple Sclerosis Society, this group will have access to thousands of classical play scripts.

Ocrelizumab getting fast tracked for primary progressive multiple sclerosis

February 26, 2016

The US Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation for the investigational medicine ocrelizumab (OCREVUS™) for the treatment of people with primary progressive multiple sclerosis (PPMS). There is currently no approved treatment for PPMS - a debilitating form of MS characterized by progressive, worsening symptoms and typically without distinct relapses or periods of remission.

Join the Swedish Team and walk to create a world free of MS

February 16, 2016

Join us Sunday, April 10, for the annual National MS Society Walk to raise awareness and help fund MS research. Register and help us make a powerful statement—and a real difference in the lives of people living with Multiple Sclerosis.

Meet Swedish MS Experts in Centralia on March 12

February 12, 2016

Experts from the Multiple Sclerosis Center at Swedish Neuroscience Institute and the National Multiple Sclerosis Society are bringing a traveling roadshow of MS education and information to Centralia in March. Learn how to RSVP for this free event.

Dr. James Bowen makes Seattle’s Top Doctors list

February 01, 2016

James Bowen, M.D., the medical director of the MS Center at Swedish, was named to the 2016 list of Top Doctors in Seattle. Learn about his philosophy of caring for people with multiple sclerosis.

« Previous 12345 Next »